|
Phenotype (CD45RA, CD45RO) of tetramer-positive CD8+ cells in individual groups |
||||||
| Age(yr.) (n = 131) |
0–4 (n = 31) |
5–9 (n = 24) |
10–14 (n = 24) |
15–19 (n = 29) |
20–29 (n = 13) |
60–92 (n = 12) |
|
|
||||||
| % |
||||||
| CD45RA(-)45RO(+) |
12.7 ± 14.5 |
27.1 ± 22.9 |
23.3 ± 21.8 |
27.5 ± 23.5 |
21.2 ± 19.5 |
18.0 ± 26.0 |
| CD45RA(+)45RO(+) |
30.1 ± 21.8 |
24.7 ± 16.6 |
20.0 ± 11.7 |
21.4 ± 15.9 |
26.6 ± 18.2 |
21.2 ± 16.8 |
| CD45RA(-)45RO(-) |
12.7 ± 11.0 |
15.5 ± 12.0 |
12.1 ± 9.7 |
15.9 ± 12.7 |
18.4 ± 15.2 |
12.2 ± 15.5 |
| CD45RA(+)45RO(-) |
43.1 ± 20.5 |
32.7 ± 14.6 |
44.5 ± 20.4 |
35.2 ± 20.6 |
33.7 ± 18.9 |
48.5 ± 30.9 |
Komatsu et al. Immunity & Ageing 2006 3:11 doi:10.1186/1742-4933-3-11 |
||||||